RelEaze
by SymPhysis Medical
www.symphysismedical.com
RelEaze is a catheter-based drainage technology to treat a common complication of late-stage cancers called malignant pleural effusion (MPE), also known as ‘fluid on the lung’. SymPhysis Medical is developing this innovative drainage technology to treat malignant pleural effusions (MPE).

RelEaze is not currently available on the market. It will be initially targeting the US Market in 2026, then aiming for regulatory approval in Europe in 2027.
Key benefits:
  • Enables patient self management
  • Reduces the need for clinical resources
  • Shortens treatment period

Focus: Community Care, Self-Management